Phase 4 study to assess tretinoin pump for the treatment of facial acne

Journal of Drugs in Dermatology

Volumn 7, Issue 12, 2008, Pages 1129-1136

  Eichenfield, Lawrence F ^a,b   Nighland, Marge ^c   Rossi, Ana Beatris ^d   Cook Bolden, Fran ^e   Grimes, Pearl ^f   Fried, Richard ^g   Levy, Sharon ^c   Barba, A ^h   Battle, E ^h   Baumann, L ^h   Brodell, R ^h   Bucko, A ^h   Burkhart, C ^h   Callender, V ^h   Cook Bolden, F ^h   Dawes, K ^h   Del Rosso, J ^h   Dosik, J ^h   Downie, J ^h   Eichenfield, L ^h   English, P ^h   Forsha, D ^h   Fowler Jr , J ^h   Fried, R ^h   Funicella, T ^h   Gold, L ^h   Gold, M ^h   Grimes, P ^h   Gross, A ^h   Kaplan, D ^h   Kircik, L ^h   Leyden, J ^h   Loven, K ^h   Lucky, A ^h   Paller, A ^h   Rafal, E ^h   Rodriquez, D ^h   Sadick, N ^h   Schlessinger, J ^h   Schiavone, F ^h   Shavin, J ^h   Spencer, J ^h   Spiers, E ^h   Taylor, S ^h   Werschler, W ^h   Wilson, D ^h   more..

^a RADY CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNSON AND JOHNSON   (United States)

^d Johnson and Johnson Consumer and Personal Products Worldwide   (France)

^e Skin Specialty Group   (United States)

^f Vitiligo and Pigmentation Institute of Southern California   (United States)

^g Yardley Dermatology Associates   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

KERATOLYTIC AGENT; MICROSPHERE; RETINOIC ACID;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DOSE RESPONSE; FACE; FEMALE; GEL; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; PHASE 4 CLINICAL TRIAL; TREATMENT OUTCOME;

ACNE VULGARIS; ADOLESCENT; ADULT; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FACE; FEMALE; GELS; HUMANS; KERATOLYTIC AGENTS; MALE; MEDICATION ADHERENCE; MICROSPHERES; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRETINOIN; YOUNG ADULT;

EID: 60549100388     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Berger R, Rizer R, Barba A, et al. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, doubleblind, parallel-group, phase IV trial. Clin Ther. 2007;29:1086-1097. (Pubitemid 47198892)
2. Shalita AR, Rafal ES, Anderson DN, et al. Compared efficacy and safety of tretinoin 0.1% microsphere gel alone and in combination with benzoyl peroxide 6% cleanser for the treatment of acne vulgaris. Cutis. 2003;72:167-172. (Pubitemid 37229749)
3. Nyirady J, Grossman RM, Nighland M, et al. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatolog Treat. 2001;12:149-157. (Pubitemid 33116877)
4. Leyden JJ, Shalita A, Thiboutot D, et al. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment. Clin Ther. 2005;27:216-224. (Pubitemid 40462015)
5. Webster G. Mechanism-based treatment of acne vulgaris: the value of combination therapy. J Drugs Dermatol. 2005;4:281-288.
6. Liu PT, Krutizik SR, Kim J, Modlin RL. Cutting edge: All-trans retinoic acid down-regulates TLR2 expression and function. J Immunol. 2005;174:2467-2470. (Pubitemid 40279655)
7. Embil K, Nacht S. The microsponge delivery system (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul. 1996;13:575-588. (Pubitemid 26283810)
8. Nyirady J, Bennett ML. Advancement of tretinoin through the microsphere technology. Cosmetic Dermatol. 2001;August:22-24.
9. Nyirady J, Lucas C, Yusuf M, et al. The stability of tretinoin in tretinoin gel microsphere 0.1%. Cutis. 2002;70:295-298. (Pubitemid 41750803)
10. Nighland M, Yusuf M, Wisniewski S, et al. The effect of simulated solar radiation on tretinoin in tretinoin gel microsphere, 0.1%. Cutis. 2006; 77:313-316. (Pubitemid 43845324)
11. Del Rosso JQ. A qualitative and quantitative assessment of the application and use of topical acne medication by patients. Cutis. 2005;76:109-113. (Pubitemid 41290896)
12. Koo J. How do you foster medication adherence for better acne vulgaris management? Skinmed. 2003;2(4):206.
13. Finlay AY. The science of compliance. J Eur Acad Dermatol Venereol. 1999;12(Suppl 2):S77.
14. Doshi A, Zaheer A, Stiller M. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36:416-418.
15. Kircik L. Community-based trial results of combination clindamycin 1%-benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. Cutis. 2007;80(1 Suppl):10-14.
16. Tanghetti EA. Combination therapy is the standard of care. Cutis. 2005;76(2 Suppl):8-14. (Pubitemid 41290888)
17. Retin-A Micro (tretinoin gel) microsphere, 0.1% and 0.04% [package insert], Skillman, NJ: Ortho Dermatological;2002.